HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H104. A total of 1 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $802,000 | +1.4% | 2,426,300 | -0.3% | 0.74% | -22.9% |
| Q1 2020 | $791,000 | -55.4% | 2,434,000 | -3.7% | 0.96% | -39.9% |
| Q4 2019 | $1,774,000 | +13.4% | 2,527,000 | +7.4% | 1.59% | +18.0% |
| Q3 2019 | $1,564,000 | +58.9% | 2,353,153 | +297.1% | 1.35% | +95.6% |
| Q2 2019 | $984,000 | -36.5% | 592,620 | -4.4% | 0.69% | -32.5% |
| Q1 2019 | $1,550,000 | +35.6% | 619,920 | +37.8% | 1.02% | +15.2% |
| Q4 2018 | $1,143,000 | -9.4% | 449,950 | +80.2% | 0.89% | +17.0% |
| Q3 2018 | $1,261,000 | +54.9% | 249,700 | 0.0% | 0.76% | +29.8% |
| Q2 2018 | $814,000 | -10.1% | 249,700 | -0.2% | 0.58% | -28.5% |
| Q1 2018 | $905,000 | – | 250,100 | – | 0.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 535,590 | $2,705,000 | 1.58% |
| Millrace Asset Group, Inc. | 200,000 | $1,010,000 | 0.79% |
| Private Wealth Partners, LLC | 1,000,000 | $5,050,000 | 0.77% |
| PERKINS CAPITAL MANAGEMENT INC | 249,700 | $1,261,000 | 0.76% |
| Timpani Capital Management LLC | 206,119 | $1,041,000 | 0.30% |
| Diametric Capital, LP | 64,329 | $325,000 | 0.28% |
| Granahan Investment Management | 941,170 | $4,753,000 | 0.26% |
| Kalos Management, Inc. | 69,900 | $308,000 | 0.16% |
| SYMMETRY PEAK MANAGEMENT LLC | 85,000 | $429,000 | 0.15% |
| B. Riley Wealth Advisors, Inc. | 250,000 | $1,263,000 | 0.15% |